Charles River Laboratories Other Non-Current Liabilities 2010-2024 | CRL

Charles River Laboratories other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Charles River Laboratories other non-current liabilities for the quarter ending September 30, 2024 were $0.237B, a 37.19% increase year-over-year.
  • Charles River Laboratories other non-current liabilities for 2023 were $0.223B, a 27.67% increase from 2022.
  • Charles River Laboratories other non-current liabilities for 2022 were $0.175B, a 28.02% decline from 2021.
  • Charles River Laboratories other non-current liabilities for 2021 were $0.243B, a 18.34% increase from 2020.
Charles River Laboratories Annual Other Non-Current Liabilities
(Millions of US $)
2023 $223
2022 $175
2021 $243
2020 $205
2019 $183
2018 $179
2017 $195
2016 $159
2015 $89
2014 $100
2013 $71
2012 $105
2011 $108
2010 $115
2009 $122
Charles River Laboratories Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $237
2024-06-30 $225
2024-03-31 $235
2023-12-31 $223
2023-09-30 $173
2023-06-30 $177
2023-03-31 $187
2022-12-31 $175
2022-09-30 $195
2022-06-30 $195
2022-03-31 $239
2021-12-31 $243
2021-09-30 $214
2021-06-30 $207
2021-03-31 $207
2020-12-31 $205
2020-09-30 $184
2020-06-30 $176
2020-03-31 $174
2019-12-31 $183
2019-09-30 $171
2019-06-30 $181
2019-03-31 $174
2018-12-31 $179
2018-09-30 $185
2018-06-30 $197
2018-03-31 $205
2017-12-31 $195
2017-09-30 $167
2017-06-30 $164
2017-03-31 $161
2016-12-31 $159
2016-09-30 $97
2016-06-30 $96
2016-03-31 $87
2015-12-31 $89
2015-09-30 $140
2015-06-30 $111
2015-03-31 $117
2014-12-31 $100
2014-09-30 $98
2014-06-30 $103
2014-03-31 $70
2013-12-31 $71
2013-09-30 $102
2013-06-30 $105
2013-03-31 $107
2012-12-31 $105
2012-09-30 $97
2012-06-30 $99
2012-03-31 $100
2011-12-31 $108
2011-09-30 $100
2011-06-30 $106
2011-03-31 $111
2010-12-31 $115
2010-09-30 $104
2010-06-30 $107
2010-03-31 $118
2009-12-31 $122
2009-09-30 $125
2009-06-30 $115
2009-03-31 $116
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00